Literature DB >> 20660186

Antiviral susceptibility of avian and swine influenza virus of the N1 neuraminidase subtype.

Terri D Stoner1, Scott Krauss, Rebecca M DuBois, Nicholas J Negovetich, David E Stallknecht, Dennis A Senne, Marie R Gramer, Seth Swafford, Tom DeLiberto, Elena A Govorkova, Robert G Webster.   

Abstract

Influenza viruses of the N1 neuraminidase (NA) subtype affecting both animals and humans caused the 2009 pandemic. Anti-influenza virus NA inhibitors are crucial early in a pandemic, when specific influenza vaccines are unavailable. Thus, it is urgent to confirm the antiviral susceptibility of the avian viruses, a potential source of a pandemic virus. We evaluated the NA inhibitor susceptibilities of viruses of the N1 subtype isolated from wild waterbirds, swine, and humans. Most avian viruses were highly or moderately susceptible to oseltamivir (50% inhibitory concentration [IC(50)], <5.1 to 50 nM). Of 91 avian isolates, 7 (7.7%) had reduced susceptibility (IC(50), >50 nM) but were sensitive to the NA inhibitors zanamivir and peramivir. Oseltamivir susceptibility ranged more widely among the waterbird viruses (IC(50), 0.5 to 154.43 nM) than among swine and human viruses (IC(50), 0.33 to 2.56 nM). Swine viruses were sensitive to oseltamivir, compared to human seasonal H1N1 isolated before 2007 (mean IC(50), 1.4 nM). Avian viruses from 2007 to 2008 were sensitive to oseltamivir, in contrast to the emergence of resistant H1N1 in humans. Susceptibility remained high to moderate over time among influenza viruses. Sequence analysis of the outliers did not detect molecular markers of drug-resistance (e.g., H275Y NA mutation [N1 numbering]) but revealed mutations outside the NA active site. In particular, V267I, N307D, and V321I residue changes were found, and structural analyses suggest that these mutations distort hydrophobic pockets and affect residues in the NA active site. We determined that natural oseltamivir resistance among swine and wild waterbirds is rare. Minor naturally occurring variants in NA can affect antiviral susceptibility.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20660186      PMCID: PMC2937791          DOI: 10.1128/JVI.00296-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia.

Authors:  Aeron C Hurt; Ian G Barr; Christopher J Durrant; Robert P Shaw; Helen M Sjogren; Alan W Hampson
Journal:  Commun Dis Intell Q Rep       Date:  2003

2.  Oseltamivir resistance during treatment of influenza A (H5N1) infection.

Authors:  Menno D de Jong; Tan Thanh Tran; Huu Khanh Truong; Minh Hien Vo; Gavin J D Smith; Vinh Chau Nguyen; Van Cam Bach; Tu Qui Phan; Quang Ha Do; Yi Guan; J S Malik Peiris; Tinh Hien Tran; Jeremy Farrar
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

3.  Pandemic influenza A(H1N1)v viruses currently circulating in New Zealand are sensitive to oseltamivir.

Authors:  R J Hall; M P Peacey; J C Ralston; J Bocacao; M Ziki; W Gunn; A Quirk; Q S Huang
Journal:  Euro Surveill       Date:  2009-07-30

4.  Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate.

Authors:  M Potier; L Mameli; M Bélisle; L Dallaire; S B Melançon
Journal:  Anal Biochem       Date:  1979-04-15       Impact factor: 3.365

5.  Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice.

Authors:  O Ferraris; N Kessler; B Lina
Journal:  Antiviral Res       Date:  2005-10       Impact factor: 5.970

6.  Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia.

Authors:  K S Li; Y Guan; J Wang; G J D Smith; K M Xu; L Duan; A P Rahardjo; P Puthavathana; C Buranathai; T D Nguyen; A T S Estoepangestie; A Chaisingh; P Auewarakul; H T Long; N T H Hanh; R J Webby; L L M Poon; H Chen; K F Shortridge; K Y Yuen; R G Webster; J S M Peiris
Journal:  Nature       Date:  2004-07-08       Impact factor: 49.962

7.  H1N1 2009 influenza virus infection during pregnancy in the USA.

Authors:  Denise J Jamieson; Margaret A Honein; Sonja A Rasmussen; Jennifer L Williams; David L Swerdlow; Matthew S Biggerstaff; Stephen Lindstrom; Janice K Louie; Cara M Christ; Susan R Bohm; Vincent P Fonseca; Kathleen A Ritger; Daniel J Kuhles; Paula Eggers; Hollianne Bruce; Heidi A Davidson; Emily Lutterloh; Meghan L Harris; Colleen Burke; Noelle Cocoros; Lyn Finelli; Kitty F MacFarlane; Bo Shu; Sonja J Olsen
Journal:  Lancet       Date:  2009-07-28       Impact factor: 79.321

8.  Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009.

Authors:  Seema Jain; Laurie Kamimoto; Anna M Bramley; Ann M Schmitz; Stephen R Benoit; Janice Louie; David E Sugerman; Jean K Druckenmiller; Kathleen A Ritger; Rashmi Chugh; Supriya Jasuja; Meredith Deutscher; Sanny Chen; John D Walker; Jeffrey S Duchin; Susan Lett; Susan Soliva; Eden V Wells; David Swerdlow; Timothy M Uyeki; Anthony E Fiore; Sonja J Olsen; Alicia M Fry; Carolyn B Bridges; Lyn Finelli
Journal:  N Engl J Med       Date:  2009-10-08       Impact factor: 91.245

Review 9.  Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans.

Authors:  J S Malik Peiris; Leo L M Poon; Yi Guan
Journal:  J Clin Virol       Date:  2009-06-11       Impact factor: 3.168

10.  Influenza: an emerging disease.

Authors:  R G Webster
Journal:  Emerg Infect Dis       Date:  1998 Jul-Sep       Impact factor: 6.883

View more
  18 in total

1.  The significance of naturally occurring neuraminidase quasispecies of H5N1 avian influenza virus on resistance to oseltamivir: a point of concern.

Authors:  Nalini Schaduangrat; Jiraphorn Phanich; Thanyada Rungrotmongkol; Hatairat Lerdsamran; Pilaipan Puthavathana; Sukathida Ubol
Journal:  J Gen Virol       Date:  2016-03-02       Impact factor: 3.891

2.  Neuraminidase inhibitor sensitivity and receptor-binding specificity of Cambodian clade 1 highly pathogenic H5N1 influenza virus.

Authors:  M Naughtin; J C Dyason; S Mardy; S Sorn; M von Itzstein; P Buchy
Journal:  Antimicrob Agents Chemother       Date:  2011-02-22       Impact factor: 5.191

3.  Influenza A viruses of swine circulating in the United States during 2009-2014 are susceptible to neuraminidase inhibitors but show lineage-dependent resistance to adamantanes.

Authors:  Tatiana Baranovich; Justin Bahl; Bindumadhav M Marathe; Marie Culhane; Evelyn Stigger-Rosser; Daniel Darnell; Bryan S Kaplan; James F Lowe; Richard J Webby; Elena A Govorkova
Journal:  Antiviral Res       Date:  2015-02-19       Impact factor: 5.970

4.  Susceptibility of avian influenza viruses of the N6 subtype to the neuraminidase inhibitor oseltamivir.

Authors:  Terri D Stoner; Scott Krauss; Jasmine C M Turner; Patrick Seiler; Nicholas J Negovetich; David E Stallknecht; Sharon Frase; Elena A Govorkova; Robert G Webster
Journal:  Antiviral Res       Date:  2012-01-10       Impact factor: 5.970

5.  Resistance to Mutant Group 2 Influenza Virus Neuraminidases of an Oseltamivir-Zanamivir Hybrid Inhibitor.

Authors:  Yan Wu; Feng Gao; Jianxun Qi; Yuhai Bi; Lifeng Fu; Sankar Mohan; Yuhang Chen; Xuebing Li; B Mario Pinto; Christopher J Vavricka; Po Tien; George F Gao
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

6.  Drug Repurposing Identifies Inhibitors of Oseltamivir-Resistant Influenza Viruses.

Authors:  Ju Bao; Bindumadhav Marathe; Elena A Govorkova; Jie J Zheng
Journal:  Angew Chem Int Ed Engl       Date:  2016-02-02       Impact factor: 15.336

7.  Environmental levels of the antiviral oseltamivir induce development of resistance mutation H274Y in influenza A/H1N1 virus in mallards.

Authors:  Josef D Järhult; Shaman Muradrasoli; John Wahlgren; Hanna Söderström; Goran Orozovic; Gunnar Gunnarsson; Caroline Bröjer; Neus Latorre-Margalef; Jerker Fick; Roman Grabic; Johan Lennerstrand; Jonas Waldenström; Ake Lundkvist; Björn Olsen
Journal:  PLoS One       Date:  2011-09-12       Impact factor: 3.240

8.  Molecular epidemiology of influenza A virus infection in Cyprus in four consecutive seasons (2009 pandemic-2013).

Authors:  C Panayiotou; J Richter; S Bashiardes; D Koptides; C Tryfonos; C Christodoulou
Journal:  Epidemiol Infect       Date:  2013-10-24       Impact factor: 4.434

9.  The potential of avian H1N1 influenza A viruses to replicate and cause disease in mammalian models.

Authors:  Zeynep A Koçer; Scott Krauss; David E Stallknecht; Jerold E Rehg; Robert G Webster
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

10.  Oseltamivir (Tamiflu(®)) in the environment, resistance development in influenza A viruses of dabbling ducks and the risk of transmission of an oseltamivir-resistant virus to humans - a review.

Authors:  Josef D Järhult
Journal:  Infect Ecol Epidemiol       Date:  2012-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.